TERT and hepatocellular carcinoma: In order to identify the role of TERT promoter mutations and CTNNB1 mutations in hepatocarcinogenesis and the pathogenesis of recurrent HCC, we performed the mutational analyses in full spectrum of precancerous lesions and HCC and in 8 pairs of matched primary and relapsed HCCs.